

Medical food and dietary supplement developer Provexis disappointed investors with widened losses for the six months ended 30 September. The share pri...


Medical food and dietary supplement developer Provexis reported a wider pre-tax loss, hurt by increased research and development expenses, while its p...


Medical food and dietary supplement developer Provexis said pre-tax losses almost doubled as it increased research and development spending. Investme...


The board of functional and medical food company Provexis has set itself the task in the coming year of maximising the commercial opportunity for Frui...


Functional foods developer Provexis has gained approval from the European Food Safety Authority (EFSA) to use its Fruitflow technology in dietary supp...


LONDON (Dow Jones)--Provexis PLC (PXS.LN), a company which focuses on the discovery, development and licensing of scientifically-proven functional foo...


LONDON (Dow Jones)--Provexis PLC (PXS.LN), which focuses on the discovery, development and licensing of scientifically-proven functional food, medical...


The movements of the blue-chip index looked like they were being directed by the grand old Duke of York on Wednesday, with the market finishing neithe...